MARKET

FHTX

FHTX

Foghorn Therapeutics Inc.
NASDAQ
5.40
+0.25
+4.85%
After Hours: 5.38 -0.02 -0.37% 16:49 12/31 EST
OPEN
5.15
PREV CLOSE
5.15
HIGH
5.54
LOW
5.15
VOLUME
146.77K
TURNOVER
--
52 WEEK HIGH
6.79
52 WEEK LOW
2.945
MARKET CAP
305.38M
P/E (TTM)
-4.7112
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FHTX last week (1222-1226)?
Weekly Report · 12/29/2025 09:40
Weekly Report: what happened at FHTX last week (1215-1219)?
Weekly Report · 12/22/2025 09:40
3 ‘Strong Buy’ Stocks to Buy Today,12/18/2025, According to Top Analysts
TipRanks · 12/18/2025 13:18
FOGHORN THERAPEUTICS INC <FHTX.O>: BTIG INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $11
Reuters · 12/18/2025 13:08
Foghorn Therapeutics Price Target Announced at $11.00/Share by BTIG
Dow Jones · 12/18/2025 12:29
Foghorn Therapeutics Initiated at Buy by BTIG
Dow Jones · 12/18/2025 12:29
BTIG Initiates Coverage On Foghorn Therapeutics with Buy Rating, Announces Price Target of $11
Benzinga · 12/18/2025 12:19
Evercore ISI Sticks to Their Buy Rating for Foghorn Therapeutics (FHTX)
TipRanks · 12/18/2025 11:56
More
About FHTX
Foghorn Therapeutics Inc. is a clinical-stage, precision therapeutics biotechnology company. The Company is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control platform, it is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The Company is also developing multiple product candidates in oncology. The Gene Traffic Control platform provides an integrated and mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing to identify, validate and potentially drug targets within this system. Its platform enables to produce components of the chromatin regulatory system at scale, thereby allowing to identify these genetic dependencies, understand their mechanism and target their vulnerabilities.

Webull offers Foghorn Therapeutics Inc stock information, including NASDAQ: FHTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FHTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FHTX stock methods without spending real money on the virtual paper trading platform.